Range
- - -
Vol / Avg.
3K/1.6M
Div / Yield
-
52 Wk
0.6 - 1.85
Mkt Cap
83.3M
Payout Ratio
-
Open
-
P/E
-
EPS
-0.06
Shares
101.9M
Outstanding
101.9M
Total Float
101.8M
load more
Sector: Health Care.Industry: Biotechnology
Diffusion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy. The company's lead product candidate is trans sodium crocetinate (TSC), which is used for the treatment of glioblastoma multiforme (GBM) and metastatic brain cancer. Geographically business activity of the firm functions through the region of the US.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-09
REV
Q1 2021Est.ActualSurprise
EPS-0.040-0.060 -0.0200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
DFFNDiffusion Pharmaceuticals-2.08%83.3M

Diffusion Pharmaceuticals Frequently Asked Questions

Q

How do I buy Diffusion Pharmaceuticals (DFFN) stock?

A

You can purchase shares of Diffusion Pharmaceuticals (NASDAQ: DFFN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Diffusion Pharmaceuticals's (DFFN) competitors?

Q

What is the target price for Diffusion Pharmaceuticals (DFFN) stock?

A

The latest price target for Diffusion Pharmaceuticals (NASDAQ: DFFN) was reported by HC Wainwright & Co. on November 17, 2020. The analyst firm set a price target for 0.00 expecting DFFN to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Diffusion Pharmaceuticals (DFFN)?

A

The stock price for Diffusion Pharmaceuticals (NASDAQ: DFFN) is $0.817 last updated Wed Jun 23 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Diffusion Pharmaceuticals (DFFN) pay a dividend?

A

There are no upcoming dividends for Diffusion Pharmaceuticals.

Q

When is Diffusion Pharmaceuticals (NASDAQ:DFFN) reporting earnings?

A
Diffusion Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 9, 2021.
Q

Is Diffusion Pharmaceuticals (DFFN) going to split?

A

There is no upcoming split for Diffusion Pharmaceuticals.

Q

What sector and industry does Diffusion Pharmaceuticals (DFFN) operate in?

A

Diffusion Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.